In the present study, we investigated the relationships between serum concentrations of mood stabilizers and cognitive functioning in bipolar and related psychotic disorders.
The stress response was determined by means of salivary cortisol concentrations, Profile Of Mood State (POMS) and State Trait Anxiety Inventory (STAI) questionnaires.
Like pharmaceutical antidepressants, ayahuasca seems to alter concentrations of the mood-boosting neurotransmitter serotonin in the brain.
Multi-level modeling analysis revealed significant associations between the concentration of nature and daily mood in participating adolescents, even after controlling for intra-individual and inter-individual level confounding variables.
Awakening salivary cortisol, 45 46 urinary oxidative stress, 47 48 plasma BDNF, 49 cognitive function according to the screen for cognitive impairment in psychiatry (SCIP-S) 50 51 and adherence to medication as measured by plasma concentration of the prescribed medicine (mood stabilisers, antipsychotics, antidepressants).
This is probably due to the fact that nocturia interferes with the quality of sleep which may have a significant negative impact on how the patient feels the next day in terms of energy level, concentration and mood and ultimately his overall quality of life (QoL).
44 Biological samples of awakening salivary cortisol, 45 46 urinary oxidative stress, 47 48 plasma BDNF 49 and adherence to medication as measured by plasma concentration of the patient-prescribed medicine (mood stabilisers, antipsychotics, antidepressants) were taken at baseline, after 3 and 6 months.
Experimental studies have demonstrated that a shift in bedtime by two hours while maintaining the same sleep duration resulted in increased feelings of depression, difficulty in concentration and mood changes [ 5].
Despite this hint, generations of psychiatrists studying thyroid effects on mood may have been frustrated or misled by the poor correlations between peripheral blood indices of thyroid function and mood, which may result from poor correlations between the T3 concentrations in the blood versus the T3 concentrations in the basal hypothalamus that might be the crucial determinant of mood symptoms.
